Treatment of Deficient Subclass or Anti-polysaccharide Antibody Response

PHASE4CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
IgG DeficiencyInfections
Interventions
DRUG

intravenous immunoglobulins

"* Adults: 600 mg/kg bodyweight every 3 weeks~* Children: 800 mg/kg bodyweight every 3 week"

DRUG

antibiotics

"* Children ≥5-12: If well tolerated, 4 mg trimethoprim and 20 mg sulfamethoxazole per kg bodyweight once daily, every day of the week (max160/800mg/day), combined with 5 mg folic acid.~* Adults and children ≥12 years or ≥40 kg: If well tolerated, 160 mg trimethoprim and 800 mg sulfamethoxazole once daily, every day of the week combined with 5 mg folic acid."

Trial Locations (9)

Unknown

Jeroen Bosch Ziekenhuis, 's-Hertogenbosch

AMC, Amsterdam

VU, Amsterdam

UMCG, Groningen

LUMC, Leiden

AZM, Maastricht

UMC St Radboud, Nijmegen

Erasmus MC, Rotterdam

UMCU, Utrecht

Sponsors
All Listed Sponsors
lead

Prothya Biosolutions

INDUSTRY

NCT00522821 - Treatment of Deficient Subclass or Anti-polysaccharide Antibody Response | Biotech Hunter | Biotech Hunter